Abbott Laboratories (ABT) COM STK NPV

Sell:$127.25Buy:$129.53$0.54 (0.42%)

Prices delayed by at least 15 minutes
Sell:$127.25
Buy:$129.53
Change:$0.54 (0.42%)
Prices delayed by at least 15 minutes
Sell:$127.25
Buy:$129.53
Change:$0.54 (0.42%)
Prices delayed by at least 15 minutes

Company Information

About this company

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Key people

Robert B. Ford
Chairman of the Board, Chief Executive Officer
Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Mary K. Moreland
Executive Vice President - Human Resources
Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Louis H. Morrone
Executive Vice President - Core Diagnostics
Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Andrea Wainer
Executive Vice President - Rapid and Molecular Diagnostics
Randel W. Woodgrift
Senior Vice President - Cardio Rhythm Management
John Arthur Mccoy
Vice President - Finance, Controller
Nancy Mckinstry
Lead Independent Director
Robert J. Alpern
Independent Director
Claire Babineaux-Fontenot
Independent Director
Sally E. Blount
Independent Director
Patricia Paola Gonzalez
Independent Director
Click to see more

Key facts

  • EPIC
    ABT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US0028241000
  • Market cap
    $219.83bn
  • Employees
    114,000
  • Shares in issue
    2.00bn
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.